CIK: 0001622627
申報總市值
US$2.5億
申報季度: 2026-03-31 · 持股檔數: 38
Rosalind Advisors, Inc.在最新一期 13F 報告中揭露了 38 項持股，申報期為 2026-03-31，總持股市值約為 US$2.5億，季度換手率為 69.1%。
目前產業板塊分類約涵蓋此投資組合揭露價值的 0%；其餘部分（例如未對應板塊的標的、選擇權或其他證券類型）尚未納入板塊分類範圍。
減碼 VRDN
-44.4% -US$910.6萬
減碼 HELP
-7.6% -US$620.6萬
加碼 XERS
+53.0% US$216.7萬
加碼 XFOR
+23.4% US$285.3萬
減碼 CGON
-66.7% -US$568.8萬
加碼 76029N906
+452.4% US$273.5萬
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DCTH | Delcath Systems INC | 股票-其他 | 12.31% | +0.71% | — | |
| 2 | XERS | Xeris Biopharma Holdings INC | 股票-其他 | 7.53% | +1.70% | +53.04% | |
| 3 | FENC | Fennec Pharmaceuticals INC | 股票-其他 | 7.19% | +0.12% | +11.28% | |
| 4 | SVRA | Savara INC | 股票-其他 | 7.03% | -0.18% | -5.88% | |
| 5 | PCVX | Vaxcyte INC | 股票-其他 | 6.77% | +6.77% | NEW | |
| 6 | EYPT | Eyepoint INC | 股票-其他 | 5.37% | +0.94% | +50.25% | |
| 7 | XFOR | X4 Pharmaceuticals INC | 股票-其他 | 5.33% | +1.67% | +23.36% | |
| 8 | VOR | Vor Biopharma INC | 股票-其他 | 5.02% | +5.02% | NEW | |
| 9 | ✓ | Mediwound LTD | 股票-其他 | 4.85% | -0.01% | — | |
| 10 | VSTM | Verastem INC | 股票-其他 | 4.55% | -0.30% | +19.57% | |
| 11 | CLDX | Celldex Therapeutics INC | 股票-其他 | 4.21% | +4.21% | NEW | |
| 12 | BCRX | Biocryst Pharmaceuticals INC | 股票-其他 | 3.53% | +3.53% | NEW | |
| 13 | HELP | Cybin INC | 股票-其他 | 2.95% | -1.82% | -7.59% | |
| 14 | CGON | Cg Oncology INC | 股票-其他 | 2.72% | -1.66% | -66.67% | |
| 15 | NSPR | Inspiremd INC | 股票-其他 | 2.56% | +0.12% | — | |
| 16 | AVIR | Atea Pharmaceuticals INC | 股票-其他 | 2.53% | +2.53% | NEW | |
| 17 | PROF | Profound Medical CORP | 股票-其他 | 2.16% | -0.80% | -22.53% | |
| 18 | VRDN | Viridian Therapeutics INC | 股票-其他 | 1.97% | -2.95% | -44.36% | |
| 19 | ✓ | Replimune Group INC | 股票-其他 | 1.10% | +1.10% | +452.45% | |
| 20 | ✓ | Polypid LTD | 股票-其他 | 1.05% | -0.01% | -14.16% | |
| 21 | MYO | Myomo INC | 股票-其他 | 1.04% | -0.19% | +0.20% | |
| 22 | TLPH | Talphera INC | 股票-其他 | 1.01% | -0.42% | -6.30% | |
| 23 | OVID | Ovid Therapeutics INC | 股票-其他 | 0.99% | +0.99% | NEW | |
| 24 | DFTX | Definium Therapeutics INC | 股票-其他 | 0.95% | +0.95% | NEW | |
| 25 | OKUR | Onkure Therapeutics Inc-a | 股票-其他 | 0.74% | — | -39.25% | |
| 26 | LPCN | Lipocine INC | 股票-其他 | 0.71% | +0.71% | NEW | |
| 27 | NRXS | Neuraxis INC | 股票-其他 | 0.68% | +0.31% | — | |
| 28 | AVTX | Avalo Therapeutics INC | 股票-其他 | 0.45% | +0.45% | NEW | |
| 29 | ANNX | Annexon INC | 股票-其他 | 0.45% | +0.45% | NEW | |
| 30 | ✓ | 股票-其他 | 0.42% | -0.64% | -44.44% | ||
| 31 | AQST | Aquestive Therapeutics INC | 股票-其他 | 0.42% | +0.42% | NEW | |
| 32 | ✓ | Spdr S&p 500 ETF Tr | ETF-大型股與成長 | 0.39% | -0.27% | -75.49% | |
| 33 | BFRI | Biofrontera INC | 股票-其他 | 0.38% | +0.15% | +2.03% | |
| 34 | KURA | Kura Oncology INC | 股票-其他 | 0.33% | -0.04% | — | |
| 35 | ✓ | Regentis Biomaterials LTD | 股票-其他 | 0.31% | -0.29% | — | |
| 36 | ✓ | Viridian Therapeutics INC | 股票-其他 | 0.02% | +0.02% | NEW | |
| 37 | ✓ | Arrivent Biopharma INC | 股票-其他 | — | -0.19% | +0.93% | |
| 38 | ✓ | Uniqure NV | 股票-其他 | — | -0.03% | +195.80% |
Q3 2026績效
+30.2%
近4個季度績效
+36.2%
根據可取得價格的持股（佔申報價值的67%）計算
尚無足夠的產業對照資料
| 季度 | 持股檔數 | 總市值 | 穩定性 | 主要持股 |
|---|---|---|---|---|
| 2026-03-31 | 38 | US$2.5億 | 69 | |
| 2025-12-31 | 42 | US$2.8億 | 49 | |
| 2025-09-30 | 39 | US$2.9億 | 87 | |
| 2025-06-30 | 37 | US$2.1億 | 0 | |
| 2025-03-31 | 34 | US$2.1億 | 0 | |
| 2024-12-31 | 40 | US$2.0億 | 0 | |
| 2024-09-30 | 33 | US$1.6億 | 0 | |
| 2024-06-30 | 40 | US$1.3億 | 0 | |
| 2024-03-31 | 34 | US$1.1億 | 0 | |
| 2023-12-31 | 30 | US$1.2億 | 0 |
Rosalind Advisors, Inc. 在 2026-03-31 最顯著的持倉異動： 新建倉: Vaxcyte INC (PCVX); 清倉: Replimune Group INC (REPL); 清倉: Atyr Pharma INC (ATYR); 新建倉: Vor Biopharma INC (VOR); 清倉: Cytokinetics INC (CYTK).
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | XERS | Xeris Biopharma Holdings INC | +1.7% | +53.04% | 加碼 |
| 2 | XFOR | X4 Pharmaceuticals INC | +1.7% | +23.36% | 加碼 |
| 3 | ✓ | Replimune Group INC | +1.1% | +452.45% | 加碼 |
| 4 | EYPT | Eyepoint INC | +0.9% | +50.25% | 加碼 |
| 5 | DCTH | Delcath Systems INC | +0.7% | — | 不變 |
| 6 | NRXS | Neuraxis INC | +0.3% | — | 不變 |
| 7 | BFRI | Biofrontera INC | +0.2% | +2.03% | 加碼 |
| 8 | FENC | Fennec Pharmaceuticals INC | +0.1% | +11.28% | 加碼 |
| 9 | NSPR | Inspiremd INC | +0.1% | — | 不變 |
| 10 | OKUR | Onkure Therapeutics Inc-a | — | -39.25% | 減碼 |
| 11 | ✓ | Mediwound LTD | 0% | — | 不變 |
| 12 | ✓ | Polypid LTD | 0% | -14.16% | 減碼 |
| 13 | ✓ | Uniqure NV | 0% | +195.80% | 加碼 |
| 14 | KURA | Kura Oncology INC | 0% | — | 不變 |
| 15 | SVRA | Savara INC | -0.2% | -5.88% | 減碼 |
| 16 | MYO | Myomo INC | -0.2% | +0.20% | 加碼 |
| 17 | ✓ | Arrivent Biopharma INC | -0.2% | +0.93% | 加碼 |
| 18 | ✓ | Spdr S&p 500 ETF Tr | -0.3% | -75.49% | 減碼 |
| 19 | ✓ | Regentis Biomaterials LTD | -0.3% | — | 不變 |
| 20 | VSTM | Verastem INC | -0.3% | +19.57% | 加碼 |
| 21 | TLPH | Talphera INC | -0.4% | -6.30% | 減碼 |
| 22 | ✓ | -0.6% | -44.44% | 減碼 | |
| 23 | PROF | Profound Medical CORP | -0.8% | -22.53% | 減碼 |
| 24 | CGON | Cg Oncology INC | -1.7% | -66.67% | 減碼 |
| 25 | HELP | Cybin INC | -1.8% | -7.59% | 減碼 |
| 26 | VRDN | Viridian Therapeutics INC | -3% | -44.36% | 減碼 |
| 27 | PCVX | Vaxcyte INC | — | NEW | 新建倉 |
| 28 | REPL | Replimune Group INC | — | EXIT | 清倉 |
| 29 | ATYR | Atyr Pharma INC | — | EXIT | 清倉 |
| 30 | VOR | Vor Biopharma INC | — | NEW | 新建倉 |
| 31 | CYTK | Cytokinetics INC | — | EXIT | 清倉 |
| 32 | CLDX | Celldex Therapeutics INC | — | NEW | 新建倉 |
| 33 | BRD1EUR | Mind Medicine Mindmed INC | — | EXIT | 清倉 |
| 34 | BCRX | Biocryst Pharmaceuticals INC | — | NEW | 新建倉 |
| 35 | AVIR | Atea Pharmaceuticals INC | — | NEW | 新建倉 |
| 36 | OCUL | Ocular Therapeutix INC | — | EXIT | 清倉 |
| 37 | AVBP | Arrivent Biopharma INC | — | EXIT | 清倉 |
| 38 | OVID | Ovid Therapeutics INC | — | NEW | 新建倉 |
| 39 | DFTX | Definium Therapeutics INC | — | NEW | 新建倉 |
| 40 | ✓ | Anavex Life Sciences CORP | — | EXIT | 清倉 |
| 41 | LPCN | Lipocine INC | — | NEW | 新建倉 |
| 42 | ✓ | Spdr Series Trust | — | EXIT | 清倉 |
| 43 | TRVI | Trevi Therapeutics INC | — | EXIT | 清倉 |
| 44 | AVTX | Avalo Therapeutics INC | — | NEW | 新建倉 |
| 45 | ✓ | Ishares Tr | — | EXIT | 清倉 |
| 46 | ANNX | Annexon INC | — | NEW | 新建倉 |
| 47 | AQST | Aquestive Therapeutics INC | — | NEW | 新建倉 |
| 48 | GUTS | Fractyl Health INC | — | EXIT | 清倉 |
| 49 | ✓ | Verastem INC | — | EXIT | 清倉 |
| 50 | ✓ | Viridian Therapeutics INC | — | NEW | 新建倉 |
| 季度 | 申報日期 | 類型 | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025-12-31 | 2026-02-12 | 13F-HR | 在 EDGAR 上查看 |
| 2025-09-30 | 2025-11-13 | 13F-HR | 在 EDGAR 上查看 |
| 2025-06-30 | 2025-08-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025-03-31 | 2025-05-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024-12-31 | 2025-02-14 | 修正案 | 在 EDGAR 上查看 |
| 2024-12-31 | 2025-02-11 | 13F-HR | 在 EDGAR 上查看 |
| 2024-09-30 | 2024-10-30 | 13F-HR | 在 EDGAR 上查看 |
| 2024-06-30 | 2024-07-12 | 13F-HR | 在 EDGAR 上查看 |
| 2024-03-31 | 2024-04-25 | 13F-HR | 在 EDGAR 上查看 |
| 2023-12-31 | 2024-02-14 | 13F-HR | 在 EDGAR 上查看 |
資產規模相近的機構
CIK 0001904152
申報總市值
US$2.5億
92 stks
2026-03-31
資產規模與本機構相差僅 0.0%
CIK 0001929349
申報總市值
US$2.5億
89 stks
2026-03-31
資產規模與本機構相差僅 0.0%
CIK 0001666667
申報總市值
US$2.5億
81 stks
2022-12-31
資料過舊，未更新
資產規模與本機構相差僅 0.1%
持倉風格相似的機構
CIK 0001346824
申報總市值
US$94.4億
86 stks
2026-03-31
前五大持倉重疊 1/5 檔，同樣重倉 Vaxcyte INC
CIK 0001397144
申報總市值
US$3.1億
19 stks
2022-12-31
資料過舊，未更新
前五大持倉重疊 1/5 檔，同樣重倉 Vaxcyte INC
CIK 0001512848
申報總市值
US$17.6億
26 stks
2026-03-31
前五大持倉重疊 1/5 檔，同樣重倉 Savara INC